Facts and Controversies of Testosterone Replacement Therapy in Male Hypogonadism
Image For Activity Cover
Availability
Registration Required
Release on 09/13/2022
Online Meeting
Sep 13, 2022 1:00 PM - 2:00 PM EST
Cost
$0.00
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty
  • Recommended

The prevalence  of adult onset male hypogonadism which is also known as “low T syndrome” has been rising due to increased screening and public awareness.

More and more male patients are requesting their clinicians to screen and get the treatment for “ low T syndrome”. There is also a significant rise in number of for-profit clinics which are known as  “low T clinics“ and “anti-aging clinics”. Only a minority of men who are taking TRT were properly evaluated and monitored carefully. 

While there is an increase demand of testosterone use among middle-aged male population, the benefit and risk of testosterone replacement therapy (TRT) have been hotly debated among practicing clinicians. 

Even though TRT has been used for many decades, the current body of research related to long term benefit and risk of TRT is still unclear. There are also significant controversies and dilemma in making the right diagnosis, choosing the right patient and the benefit and risk assessment of TRT.

This webinar will discuss the most relevant, up-to-date research literature which will be useful in daily clinical practice. 

The intended audience for this activity includes a wide range of health care providers; many may deem this presentation beneficial.

More information coming soon.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

FACULTY AND DISCLOSURES

Kyaw Soe, MD, Associate Professor of Internal Medicine in the Division of Endocrinology at UT Southwestern Medical Center at Dallas

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the ACCME, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's EBR faculty. There are no commercial supporters of this activity, and no commercial entities have had influence over the planning of this CME activity.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity regarding exposition or conclusion. 
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Powered By